CUV 0.71% $14.09 clinuvel pharmaceuticals limited

I don't at all appreciate the company mgmt for 2011 AND 2012...

  1. 648 Posts.
    I don't at all appreciate the company mgmt for 2011 AND 2012 telling the public on their website and in a couple marketing pieces to expect an update on cuv9900 and the start of trials.

    Once again, hardly a mention at the AGM - apparenly only when questioned about it, and then a vague answer.

    This smacks of what we went through with PLE for a couple years...

    I bought all my shares years ago because of the technology, but I sold a ton because of what I've seen from this management team. Far too many broken deadlines, far too much marlarky about PLE and cuv9900.

    And the stock price is still roughly 1/2 the value it was when Wolgen took over well over 6 years ago.

    But, they keep on bragging.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.